Nath Bio-Genes Announcements
Compliance Certificate under 74(5) of SEBI (DP) Regulation
15 Oct, 2025 | 04:01pm • Source: BSE
Record date for the purpose of Annual General Meeting.
31 Jul, 2025 | 08:55pm • Source: BSE
Compliance Certificate under Reg 74(5) of SEBI_ DP Regulation
16 Jul, 2025 | 05:09pm • Source: BSE
Investor Presentation on financial results as on 30th June 2025
11 Jul, 2025 | 05:11pm • Source: BSE
The Board of Directors of the Company at Meeting held today on 11th July 2025 has approved the following,1. Stanaldone and Consolidated Financial Results as...
11 Jul, 2025 | 04:44pm • Source: BSE
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2025 ,inter alia, to consider...
04 Jul, 2025 | 12:41pm • Source: BSE
Resignation of Additional Director (Independent).
03 Jul, 2025 | 03:16pm • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 11, 2025 for...
11 Jun, 2025 | 01:43pm • Source: BSE
Issue of Duplicate Share Certificate
03 Jun, 2025 | 04:37pm • Source: BSE
Annual Secretarial Compliance Report
30 May, 2025 | 12:10pm • Source: BSE
Intimation for issue of Duplicate Share Certificate
21 May, 2025 | 04:30pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditya Birla Sun Life Mutual...
15 May, 2025 | 03:00pm • Source: BSE
Nath Bio-Genes (India) Limited has informed the Exchange about CONFERENCE CALL
24 Apr, 2025 | 11:43am • Source: NSE
Intimation of Con Call to be held on 30th April 2025
24 Apr, 2025 | 11:17am • Source: BSE
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2025 ,inter alia, to consider...
21 Apr, 2025 | 05:15pm • Source: BSE
Issue of Duplicate share certificate
21 Apr, 2025 | 03:13pm • Source: BSE